Why the study?
Does intravenous hexamethonium improve clinical status and hemodynamics in patients with congestive heart failure?
Does intravenous hexamethonium improve clinical status and hemodynamics in patients with congestive heart failure?
Answers are grounded in this paper and cite their sources.
Intravenous hexamethonium may provide clinical and hemodynamic improvement in patients with congestive heart failure by reducing peripheral resistance.
Hypotensive doses of hexamethonium were administered intravenously to 19 patients with various types of heart disease in congestive failure. Clinical improvement as judged by the usual methods was seen in most cases. Intracardiac or pulmonary artery pressures paralleled the fall of arterial pressures following hexamethonium in four patients with hypertensive heart disease in congestive failure. It is suggested that hexamethonium, by reducing the total peripheral resistance and by a redistribution of blood volume, may interrupt the vicious cycle of heart failure.
No takes yet. Share an insight, caveat, or question.
Kelley et al. (1953) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: